DHEA treatment: Myth or reality?

Trends in Endocrinology and Metabolism

Volumn 13, Issue 7, 2002, Pages 288-294

  Allolio, Bruno ^a   Arit, Wiebke ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; NEUROTRANSMITTER RECEPTOR; PRASTERONE; SEX HORMONE; GLUCOCORTICOID; PRASTERONE SULFATE;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; AGED; AGING; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DRUG MECHANISM; HUMAN; MOOD; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUALITY; STEROIDOGENESIS; WELLBEING; AFFECT; ANIMAL; BODY COMPOSITION; FEMALE; HORMONE SUBSTITUTION; MALE; MORTALITY; PHYSIOLOGY; SKIN;

ADRENAL INSUFFICIENCY; AFFECT; AGED; AGING; ANIMALS; BODY COMPOSITION; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MORTALITY; SKIN;

EID: 0036715979     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00617-3     Document Type: Review

References (78)

1. Orentreich, N. et al. (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59, 551-555
2. Sizonenko, P.C. and Paunier, L. (1975) Hormonal changes in puberty III: correlation of plasma dehydroepiandrosterone, testosterone, FSH, and LH with stages of puberty and bone age in normal boys and girls and in patients with Addison's disease or hypogonadism or with premature or late adrenarche. J. Clin. Endocrinol. Metab. 41, 894-904
3. Reiter, E.O. et al. (1977) Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities. J. Pediatr. 90, 766-770
4. Sklar, C.A. et al. (1980) Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J. Clin. Endocrinol. Metab. 51, 548-556
5. Palmert, M.R. et al. (2001) The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J. Clin. Endocrinol. Metab. 86, 4536-4542
6. Orentreich, N. et al. (1992) Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75, 1002-1004
7. Parker, C.R. et al. (1997)Aging alters zonation in the adrenal cortex of men. J. Clin. Endocrinol. Metab. 82, 3898-3901
8. Laughlin, G.A. and Barrett-Connor, E. (2000) Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85, 3561-3568
9. Kalmijn, S. et al. (1998) A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 83, 3487-3492
10. Svec, F. and Porter, J.R. (1998) The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc. Soc. Exp. Biol. Med. 218, 174-191
11. Arlt, W. et al. (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 83, 1928-1934
12. Arlt, W. et al. (1999) Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J. Clin. Endocrinol. Metab. 84, 2170-2176
13. Bird, C.E. et al. (1984) Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin. Invest. Med. 7, 119-122
14. Martel, C. et al. (1992) Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol. 41, 597-603
15. Martel, C. et al. (1994) Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD), 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey. Mol. Cell. Endocrinol. 104, 103-111
16. Jakob, F. et al. (1997) Local estradiol metabolism in osteoblast- and osteoclast-like cells. J. Steroid Biochem. Mol. Biol. 61, 167-174
17. Krazeisen, A. et al. (1999) Determination of cDNA, gene structure and chromosomal localization of the novel human 17β-hydroxysteroid dehydrogenase type 7(1). FEBS Lett. 460, 373-379
18. English, M.A. et al. (2000) Oestrogen inactivation in the colon: analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer. Br. J. Cancer 83, 550-558
19. Labrie, F. (1991) Intracrinology. Mol. Cell. Endocrinol. 78, C113-118
20. Young, J. et al. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J. Clin. Endocrinol. Metab. 82, 2578-2585
21. Moghissi, E. et al. (1984) Origin of plasma androstanediol glucuronide in men. J. Clin. Endocrinol. Metab. 59, 417-421
22. Giagulli, V.A. et al. (1989) Precursors of plasma androstanediol- and androgen-glucuronides in women. J. Steroid Biochem. 33, 935-940
23. Corpechot, C. et al. (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 78, 4704-4707
24. Compagnone, N.A. et al. (1995) Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136, 5212-5223
25. Zwain, I.H. and Yen, S.S. (1999) Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140, 880-887
26. Zwain, I.H. and Yen, S.S. (1999) Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140, 3843-3852
27. Compagnone, N.A. and Mellon, S.H. (1998) Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U. S. A. 95, 4678-4683
28. Bergeron, R. et al. (1996) Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 16, 1193-1202
29. Majewska, M.D. et al. (1990) The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 526, 143-146
30. Demirgoren, S. et al. (1991) Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45, 127-135
31. Meikle, A.W. et al. (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol. 42, 293-304
32. Okabe, T. et al. (1995) Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J. Clin. Endocrinol. Metab. 80, 2993-2996
33. Liu, D. and Dillon, J.S. (2002) Dehydroepiandrosterone activates endothelial cell nitric oxide synthase by a specific plasma membrane receptor coupled to Gα i2,3. J. Biol. Chem. 277, 21379-21388
34. Williams, M.R. et al. (2002) Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J. Clin. Endocrinol. Metab. 87, 176-181
35. Berr, C. et al. (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. U. S. A. 93, 13410-13415
36. Trivedi, D.P. and Khaw, K.T. (2001) Dehydroepiandrosterone sulfate and mortality in elderly men and women. J. Clin. Endocrinol. Metab. 86, 4171-4177
37. Mazat, L. et al. (2001) Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci. U. S. A. 98, 8145-8150
38. Ravaglia, G. et al. (1996) The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J. Clin. Endocrinol. Metab. 81, 1173-1178
39. Parker, L. et al. (1985) Dissociation of adrenal androgen and cortisol levels in acute stress. Horm. Metab. Res. 17, 209-212
40. Miller, K.K. (2001) Androgen deficiency in women. J. Clin. Endocrinol. Metab. 86, 2395-2401
41. Riedel, M. et al. (1993) Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Exp. Clin. Endocrinol. 101, 106-111
42. Rosen, T. et al. (1994) Decreased psychological well-being in adult patients with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 40, 111-116
43. Morales, A.J. et al. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78, 1360-1367
44. Arlt, W. et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. New Engl. J. Med. 341, 1013-1020
45. Hunt, P.J. et al. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85, 4650-4656
46. Johannsson, G. et al. (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J. Clin. Endocrinol. Metab. 87, 2046-2052
47. Callies,F. et al. (2001) Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J. Clin. Endocrinol. Metab. 86, 1968-1972
48. Kim, S.S. and Brody, K.H. (2001) Dehydroepiandrosterone replacement in Addison's disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 97, 96-97
49. Oelkers, W. (1999) Dehydroepiandrosterone for adrenal insufficiency. New Engl. J. Med. 341, 1073-1074
50. Achermann, J.C. and Silverman, B.L. (2001) Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet 357, 1381-1382
51. Wolkowitz, O.M. et al. (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 156, 646-649
52. Bloch, M. et al. (1999) Dehydroepiandrosterone treatment of midlife dysthymia. Biol. Psychiatry 45, 1533-1541
53. Barnhart, K.T. et al. (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J. Clin. Endocrinol. Metab. 84, 3896-3902
54. Sugino, M. et al. (1998) A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 51, 586-589
55. Flynn, M.A. et al. (1999) Dehydroepiandrosterone replacement in aging humans. J. Clin. Endocrinol. Metab. 84, 1527-1533
56. Friess, E. et al. (1995) DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am. J. Physiol. 268, E107-E113
57. Reiter, W.J. et al. (1999) Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 53, 590-594
58. Morales, A.J. et al. (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. (Oxf.) 49, 421-432
59. Casson, P.R. et al. (1998) Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil. Steril. 70, 107-110
60. Diamond, P. et al. (1996) Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J. Endocrinol. 150 (Suppl.), S43-S50
61. Lasco, A. et al. (2001) Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur. J. Endocrinol. 145, 457-461
62. Villareal, D.T. et al. (2000) Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin. Endocrinol. (Oxf.) 53, 561-568
63. Yen, S.S. et al. (1995) Replacement of DHEA in aging men and women. Potential remedial effects. Ann. New York Acad. Sci. 774, 128-142
64. Baulieu, E.E. et al. (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U. S. A. 97, 4279-4284
65. Labrie, F. et al. (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab. 82, 3498-3505
66. Young, D.G. et al. (1999) The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor β1 (TGF-β1) levels in normal healthy blood donors. Clin. Exp. Immunol. 117, 476-481
67. Straub, R.H. et al. (1998) Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83, 2012-2017
68. Delpedro, A.D. et al. (1998) Activation of human monocytes by LPS and DHEA. J. Interferon Cytokine Res. 18, 125-135
69. Young, D.G. et al. (2001) Preliminary studies on the effect of dehydroepiandrosterone (DHEA) on both constitutive and phytohaemagglutinin (PHA)-inducible IL-6 and IL-2 mRNA expression and cytokine production in human spleen mononuclear cell suspensions in vitro. Clin. Exp. Immunol. 123, 28-35
70. McLachlan, J.A. et al. (1996) Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J. Immunol. 156, 328-335
71. Casson, P.R. et al. (1993) Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynecol. 169, 1536-1539
72. Solerte, S.B. et al. (1999) Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. J. Clin. Endocrinol. Metab. 84, 3260-3267
73. Daynes, R.A. et al. (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur. J. Immunol. 20, 793-802
74. Schmidt, M. et al. (2000) Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J. Endocrinol. 164, 161-169
75. Arlt, W. et al. (2001) Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J. Clin. Endocrinol. Metab. 86, 4686-4692
76. van Vollenhoven, R.F. et al. (1995) Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum. 38, 1826-1831
77. van Vollenhoven, R.F. et al. (1999)A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8, 181-187
78. Stoll, B.A. (1999) Dietary supplements of dehydroepiandrosterone in relation to breast cancer risk. Eur. J. Clin. Nutr. 53, 771-775